ClC-5 Downregulation Induces Osteosarcoma Cell Apoptosis by Promoting Bax and tBid Complex Formation

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Osteosarcoma is the most common primary malignant bone tumor.
• Chloride (Cl^-) channels are crucial for cancer cell function, but their role in osteosarcoma is not fully understood.
• ClC-5 expression and its impact on intracellular chloride ([Cl^-]_i) in osteosarcoma require investigation.

Purpose of the Study:

• To investigate the role of ClC-5 in osteosarcoma progression.
• To elucidate the underlying molecular mechanisms of ClC-5 in osteosarcoma cell apoptosis and viability.
• To assess the prognostic significance of ClC-5 expression in osteosarcoma patients.

Main Methods:

• Comparative analysis of ClC-5 expression in osteosarcoma and normal bone tissues.
• Measurement of intracellular chloride ([Cl^-]_i) in osteosarcoma cells and normal osteoblasts.
• ClC-5 knockdown experiments in osteosarcoma cells.
• Assessment of cell viability, apoptosis, and mitochondrial pathway activation (cytochrome c release, caspase cleavage).
• Immunoprecipitation to study protein interactions (ClC-5, Bax, tBid).

Main Results:

• ClC-5 expression is significantly upregulated in osteosarcoma tissues and cells.
• High ClC-5 expression correlates with poor patient survival.
• Lowered [Cl^-]_i in osteosarcoma cells enhances viability, an effect blocked by ClC-5 downregulation.
• ClC-5 knockdown induces apoptosis via the mitochondria-dependent pathway, involving Bax translocation and interaction with tBid, leading to caspase-9 and caspase-3 activation.
• ClC-5 interacts with Bax, and its downregulation enhances Bax and tBid complex formation.

Conclusions:

• ClC-5 is a potential prognostic biomarker for osteosarcoma.
• ClC-5 downregulation induces osteosarcoma cell apoptosis through the mitochondria-dependent pathway.
• Targeting ClC-5 may represent a novel therapeutic strategy for osteosarcoma.